nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Naloxone—CREB1—sarcoma	0.0659	1	CrCbGaD
Nalbuphine—Respiratory arrest—Thiotepa—sarcoma	0.0321	0.0344	CcSEcCtD
Nalbuphine—Respiratory distress—Vincristine—sarcoma	0.0197	0.0211	CcSEcCtD
Nalbuphine—Warmth—Epirubicin—sarcoma	0.0179	0.0191	CcSEcCtD
Nalbuphine—Warmth—Doxorubicin—sarcoma	0.0165	0.0177	CcSEcCtD
Nalbuphine—Numbness—Vincristine—sarcoma	0.0151	0.0162	CcSEcCtD
Nalbuphine—Sensory loss—Vincristine—sarcoma	0.0145	0.0155	CcSEcCtD
Nalbuphine—Tingling sensation—Etoposide—sarcoma	0.0126	0.0135	CcSEcCtD
Nalbuphine—Pulmonary oedema—Thiotepa—sarcoma	0.0126	0.0135	CcSEcCtD
Nalbuphine—Numbness—Etoposide—sarcoma	0.0122	0.0131	CcSEcCtD
Nalbuphine—Sensory loss—Etoposide—sarcoma	0.0117	0.0125	CcSEcCtD
Nalbuphine—Swelling—Mitoxantrone—sarcoma	0.01	0.0107	CcSEcCtD
Nalbuphine—Cardiac arrest—Thiotepa—sarcoma	0.00974	0.0104	CcSEcCtD
Nalbuphine—Cardiac arrest—Vincristine—sarcoma	0.00864	0.00925	CcSEcCtD
Nalbuphine—Redness—Epirubicin—sarcoma	0.00842	0.00901	CcSEcCtD
Nalbuphine—Swelling—Etoposide—sarcoma	0.00834	0.00893	CcSEcCtD
Nalbuphine—Redness—Doxorubicin—sarcoma	0.00779	0.00834	CcSEcCtD
Nalbuphine—Sweating increased—Mitoxantrone—sarcoma	0.00745	0.00798	CcSEcCtD
Nalbuphine—Feeling hot—Epirubicin—sarcoma	0.00724	0.00775	CcSEcCtD
Nalbuphine—Hallucination—Thiotepa—sarcoma	0.00705	0.00755	CcSEcCtD
Nalbuphine—Cardiac arrest—Etoposide—sarcoma	0.007	0.00749	CcSEcCtD
Nalbuphine—Depression—Vincristine—sarcoma	0.00698	0.00748	CcSEcCtD
Nalbuphine—Feeling hot—Doxorubicin—sarcoma	0.0067	0.00717	CcSEcCtD
Nalbuphine—Cramp muscle—Etoposide—sarcoma	0.00663	0.0071	CcSEcCtD
Nalbuphine—Flushing—Dactinomycin—sarcoma	0.00653	0.00699	CcSEcCtD
Nalbuphine—Bronchospasm—Etoposide—sarcoma	0.00626	0.0067	CcSEcCtD
Nalbuphine—Hallucination—Vincristine—sarcoma	0.00625	0.0067	CcSEcCtD
Nalbuphine—Hypoaesthesia—Vincristine—sarcoma	0.00625	0.0067	CcSEcCtD
Nalbuphine—Bradycardia—Mitoxantrone—sarcoma	0.00623	0.00667	CcSEcCtD
Nalbuphine—Sweating increased—Etoposide—sarcoma	0.0062	0.00663	CcSEcCtD
Nalbuphine—Erythema—Thiotepa—sarcoma	0.00617	0.00661	CcSEcCtD
Nalbuphine—Erythema—Dactinomycin—sarcoma	0.00613	0.00656	CcSEcCtD
Nalbuphine—Tension—Thiotepa—sarcoma	0.00606	0.00648	CcSEcCtD
Nalbuphine—Nervousness—Thiotepa—sarcoma	0.00599	0.00642	CcSEcCtD
Nalbuphine—Vision blurred—Thiotepa—sarcoma	0.00582	0.00623	CcSEcCtD
Nalbuphine—Agitation—Thiotepa—sarcoma	0.00567	0.00607	CcSEcCtD
Nalbuphine—Injection site reaction—Epirubicin—sarcoma	0.00565	0.00605	CcSEcCtD
Nalbuphine—Convulsion—Thiotepa—sarcoma	0.00535	0.00572	CcSEcCtD
Nalbuphine—Erythema—Mitoxantrone—sarcoma	0.00533	0.00571	CcSEcCtD
Nalbuphine—Hypertension—Thiotepa—sarcoma	0.00533	0.0057	CcSEcCtD
Nalbuphine—Anxiety—Thiotepa—sarcoma	0.00524	0.00561	CcSEcCtD
Nalbuphine—Injection site reaction—Doxorubicin—sarcoma	0.00523	0.0056	CcSEcCtD
Nalbuphine—Dysgeusia—Mitoxantrone—sarcoma	0.00522	0.00559	CcSEcCtD
Nalbuphine—Confusional state—Thiotepa—sarcoma	0.00508	0.00544	CcSEcCtD
Nalbuphine—Hypoaesthesia—Etoposide—sarcoma	0.00507	0.00542	CcSEcCtD
Nalbuphine—Pulmonary oedema—Epirubicin—sarcoma	0.00506	0.00542	CcSEcCtD
Nalbuphine—Agitation—Vincristine—sarcoma	0.00503	0.00538	CcSEcCtD
Nalbuphine—Vision blurred—Mitoxantrone—sarcoma	0.00502	0.00538	CcSEcCtD
Nalbuphine—Oedema—Dactinomycin—sarcoma	0.005	0.00535	CcSEcCtD
Nalbuphine—Vertigo—Vincristine—sarcoma	0.00492	0.00526	CcSEcCtD
Nalbuphine—Tachycardia—Thiotepa—sarcoma	0.00492	0.00526	CcSEcCtD
Nalbuphine—Convulsion—Vincristine—sarcoma	0.00474	0.00508	CcSEcCtD
Nalbuphine—Flushing—Etoposide—sarcoma	0.00473	0.00506	CcSEcCtD
Nalbuphine—Hypertension—Vincristine—sarcoma	0.00472	0.00506	CcSEcCtD
Nalbuphine—Pulmonary oedema—Doxorubicin—sarcoma	0.00468	0.00501	CcSEcCtD
Nalbuphine—Convulsion—Mitoxantrone—sarcoma	0.00462	0.00494	CcSEcCtD
Nalbuphine—Hypertension—Mitoxantrone—sarcoma	0.0046	0.00493	CcSEcCtD
Nalbuphine—Paraesthesia—Thiotepa—sarcoma	0.00452	0.00484	CcSEcCtD
Nalbuphine—Anxiety—Mitoxantrone—sarcoma	0.00452	0.00484	CcSEcCtD
Nalbuphine—Somnolence—Thiotepa—sarcoma	0.00448	0.00479	CcSEcCtD
Nalbuphine—Oedema—Vincristine—sarcoma	0.00447	0.00478	CcSEcCtD
Nalbuphine—Dyspepsia—Thiotepa—sarcoma	0.00443	0.00475	CcSEcCtD
Nalbuphine—Confusional state—Mitoxantrone—sarcoma	0.00439	0.0047	CcSEcCtD
Nalbuphine—Oedema—Mitoxantrone—sarcoma	0.00435	0.00466	CcSEcCtD
Nalbuphine—Dysgeusia—Etoposide—sarcoma	0.00434	0.00465	CcSEcCtD
Nalbuphine—Hyperhidrosis—Vincristine—sarcoma	0.00432	0.00462	CcSEcCtD
Nalbuphine—Shock—Mitoxantrone—sarcoma	0.00428	0.00458	CcSEcCtD
Nalbuphine—Muscle spasms—Etoposide—sarcoma	0.00426	0.00456	CcSEcCtD
Nalbuphine—Tachycardia—Mitoxantrone—sarcoma	0.00425	0.00454	CcSEcCtD
Nalbuphine—Hyperhidrosis—Mitoxantrone—sarcoma	0.0042	0.0045	CcSEcCtD
Nalbuphine—Hypotension—Vincristine—sarcoma	0.00417	0.00447	CcSEcCtD
Nalbuphine—Feeling abnormal—Thiotepa—sarcoma	0.00415	0.00444	CcSEcCtD
Nalbuphine—Feeling abnormal—Dactinomycin—sarcoma	0.00412	0.00441	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Thiotepa—sarcoma	0.00412	0.00441	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00409	0.00438	CcSEcCtD
Nalbuphine—Hypotension—Mitoxantrone—sarcoma	0.00406	0.00435	CcSEcCtD
Nalbuphine—Paraesthesia—Vincristine—sarcoma	0.00401	0.00429	CcSEcCtD
Nalbuphine—Urticaria—Thiotepa—sarcoma	0.004	0.00428	CcSEcCtD
Nalbuphine—Vertigo—Etoposide—sarcoma	0.00398	0.00426	CcSEcCtD
Nalbuphine—Body temperature increased—Thiotepa—sarcoma	0.00398	0.00426	CcSEcCtD
Nalbuphine—Abdominal pain—Thiotepa—sarcoma	0.00398	0.00426	CcSEcCtD
Nalbuphine—Abdominal pain—Dactinomycin—sarcoma	0.00395	0.00423	CcSEcCtD
Nalbuphine—Body temperature increased—Dactinomycin—sarcoma	0.00395	0.00423	CcSEcCtD
Nalbuphine—Cardiac arrest—Epirubicin—sarcoma	0.00392	0.0042	CcSEcCtD
Nalbuphine—Paraesthesia—Mitoxantrone—sarcoma	0.00391	0.00418	CcSEcCtD
Nalbuphine—Loss of consciousness—Etoposide—sarcoma	0.0039	0.00417	CcSEcCtD
Nalbuphine—Dyspnoea—Mitoxantrone—sarcoma	0.00388	0.00415	CcSEcCtD
Nalbuphine—Somnolence—Mitoxantrone—sarcoma	0.00387	0.00414	CcSEcCtD
Nalbuphine—Convulsion—Etoposide—sarcoma	0.00384	0.00411	CcSEcCtD
Nalbuphine—Dyspepsia—Mitoxantrone—sarcoma	0.00383	0.0041	CcSEcCtD
Nalbuphine—Hypertension—Etoposide—sarcoma	0.00383	0.0041	CcSEcCtD
Nalbuphine—Hypersensitivity—Thiotepa—sarcoma	0.00371	0.00397	CcSEcCtD
Nalbuphine—Hypersensitivity—Dactinomycin—sarcoma	0.00368	0.00394	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Vincristine—sarcoma	0.00365	0.00391	CcSEcCtD
Nalbuphine—Confusional state—Etoposide—sarcoma	0.00365	0.00391	CcSEcCtD
Nalbuphine—Cardiac arrest—Doxorubicin—sarcoma	0.00363	0.00389	CcSEcCtD
Nalbuphine—Asthenia—Thiotepa—sarcoma	0.00361	0.00387	CcSEcCtD
Nalbuphine—Asthenia—Dactinomycin—sarcoma	0.00359	0.00384	CcSEcCtD
Nalbuphine—Feeling abnormal—Mitoxantrone—sarcoma	0.00358	0.00384	CcSEcCtD
Nalbuphine—Asthma—Epirubicin—sarcoma	0.00357	0.00382	CcSEcCtD
Nalbuphine—Pruritus—Thiotepa—sarcoma	0.00356	0.00381	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00356	0.00381	CcSEcCtD
Nalbuphine—Tachycardia—Etoposide—sarcoma	0.00353	0.00378	CcSEcCtD
Nalbuphine—Abdominal pain—Vincristine—sarcoma	0.00353	0.00378	CcSEcCtD
Nalbuphine—Body temperature increased—Vincristine—sarcoma	0.00353	0.00378	CcSEcCtD
Nalbuphine—Hyperhidrosis—Etoposide—sarcoma	0.0035	0.00374	CcSEcCtD
Nalbuphine—Urticaria—Mitoxantrone—sarcoma	0.00346	0.0037	CcSEcCtD
Nalbuphine—Abdominal pain—Mitoxantrone—sarcoma	0.00344	0.00368	CcSEcCtD
Nalbuphine—Body temperature increased—Mitoxantrone—sarcoma	0.00344	0.00368	CcSEcCtD
Nalbuphine—Hypotension—Etoposide—sarcoma	0.00338	0.00362	CcSEcCtD
Nalbuphine—Dizziness—Thiotepa—sarcoma	0.00333	0.00357	CcSEcCtD
Nalbuphine—Asthma—Doxorubicin—sarcoma	0.0033	0.00353	CcSEcCtD
Nalbuphine—Pollakiuria—Epirubicin—sarcoma	0.00329	0.00353	CcSEcCtD
Nalbuphine—Hypersensitivity—Vincristine—sarcoma	0.00329	0.00352	CcSEcCtD
Nalbuphine—Paraesthesia—Etoposide—sarcoma	0.00325	0.00348	CcSEcCtD
Nalbuphine—Dyspnoea—Etoposide—sarcoma	0.00323	0.00345	CcSEcCtD
Nalbuphine—Somnolence—Etoposide—sarcoma	0.00322	0.00344	CcSEcCtD
Nalbuphine—Hypersensitivity—Mitoxantrone—sarcoma	0.0032	0.00343	CcSEcCtD
Nalbuphine—Asthenia—Vincristine—sarcoma	0.0032	0.00343	CcSEcCtD
Nalbuphine—Vomiting—Thiotepa—sarcoma	0.0032	0.00343	CcSEcCtD
Nalbuphine—Vomiting—Dactinomycin—sarcoma	0.00318	0.0034	CcSEcCtD
Nalbuphine—Rash—Thiotepa—sarcoma	0.00318	0.0034	CcSEcCtD
Nalbuphine—Dermatitis—Thiotepa—sarcoma	0.00317	0.0034	CcSEcCtD
Nalbuphine—Headache—Thiotepa—sarcoma	0.00316	0.00338	CcSEcCtD
Nalbuphine—Rash—Dactinomycin—sarcoma	0.00315	0.00337	CcSEcCtD
Nalbuphine—Asthenia—Mitoxantrone—sarcoma	0.00312	0.00334	CcSEcCtD
Nalbuphine—Pollakiuria—Doxorubicin—sarcoma	0.00305	0.00326	CcSEcCtD
Nalbuphine—Nausea—Thiotepa—sarcoma	0.00299	0.0032	CcSEcCtD
Nalbuphine—Feeling abnormal—Etoposide—sarcoma	0.00298	0.00319	CcSEcCtD
Nalbuphine—Nausea—Dactinomycin—sarcoma	0.00297	0.00318	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Etoposide—sarcoma	0.00296	0.00317	CcSEcCtD
Nalbuphine—Dizziness—Vincristine—sarcoma	0.00295	0.00316	CcSEcCtD
Nalbuphine—Bradycardia—Epirubicin—sarcoma	0.00291	0.00311	CcSEcCtD
Nalbuphine—Urticaria—Etoposide—sarcoma	0.00287	0.00308	CcSEcCtD
Nalbuphine—Abdominal pain—Etoposide—sarcoma	0.00286	0.00306	CcSEcCtD
Nalbuphine—Body temperature increased—Etoposide—sarcoma	0.00286	0.00306	CcSEcCtD
Nalbuphine—Hypoaesthesia—Epirubicin—sarcoma	0.00284	0.00304	CcSEcCtD
Nalbuphine—Vomiting—Vincristine—sarcoma	0.00284	0.00304	CcSEcCtD
Nalbuphine—Rash—Vincristine—sarcoma	0.00282	0.00301	CcSEcCtD
Nalbuphine—Dermatitis—Vincristine—sarcoma	0.00281	0.00301	CcSEcCtD
Nalbuphine—Headache—Vincristine—sarcoma	0.0028	0.003	CcSEcCtD
Nalbuphine—Vomiting—Mitoxantrone—sarcoma	0.00277	0.00296	CcSEcCtD
Nalbuphine—Rash—Mitoxantrone—sarcoma	0.00274	0.00294	CcSEcCtD
Nalbuphine—Dermatitis—Mitoxantrone—sarcoma	0.00274	0.00293	CcSEcCtD
Nalbuphine—Headache—Mitoxantrone—sarcoma	0.00272	0.00292	CcSEcCtD
Nalbuphine—Bradycardia—Doxorubicin—sarcoma	0.00269	0.00288	CcSEcCtD
Nalbuphine—Hypersensitivity—Etoposide—sarcoma	0.00267	0.00285	CcSEcCtD
Nalbuphine—Nausea—Vincristine—sarcoma	0.00265	0.00284	CcSEcCtD
Nalbuphine—Flushing—Epirubicin—sarcoma	0.00265	0.00284	CcSEcCtD
Nalbuphine—Hypoaesthesia—Doxorubicin—sarcoma	0.00263	0.00281	CcSEcCtD
Nalbuphine—Asthenia—Etoposide—sarcoma	0.0026	0.00278	CcSEcCtD
Nalbuphine—Nausea—Mitoxantrone—sarcoma	0.00258	0.00277	CcSEcCtD
Nalbuphine—Pruritus—Etoposide—sarcoma	0.00256	0.00274	CcSEcCtD
Nalbuphine—Erythema—Epirubicin—sarcoma	0.00248	0.00266	CcSEcCtD
Nalbuphine—Flushing—Doxorubicin—sarcoma	0.00245	0.00262	CcSEcCtD
Nalbuphine—Tension—Epirubicin—sarcoma	0.00244	0.00261	CcSEcCtD
Nalbuphine—Dysgeusia—Epirubicin—sarcoma	0.00243	0.00261	CcSEcCtD
Nalbuphine—Nervousness—Epirubicin—sarcoma	0.00241	0.00258	CcSEcCtD
Nalbuphine—Dizziness—Etoposide—sarcoma	0.00239	0.00256	CcSEcCtD
Nalbuphine—Muscle spasms—Epirubicin—sarcoma	0.00239	0.00256	CcSEcCtD
Nalbuphine—Vision blurred—Epirubicin—sarcoma	0.00234	0.00251	CcSEcCtD
Nalbuphine—Vomiting—Etoposide—sarcoma	0.0023	0.00246	CcSEcCtD
Nalbuphine—Erythema—Doxorubicin—sarcoma	0.0023	0.00246	CcSEcCtD
Nalbuphine—Agitation—Epirubicin—sarcoma	0.00228	0.00244	CcSEcCtD
Nalbuphine—Rash—Etoposide—sarcoma	0.00228	0.00244	CcSEcCtD
Nalbuphine—Dermatitis—Etoposide—sarcoma	0.00228	0.00244	CcSEcCtD
Nalbuphine—Headache—Etoposide—sarcoma	0.00227	0.00243	CcSEcCtD
Nalbuphine—Tension—Doxorubicin—sarcoma	0.00226	0.00242	CcSEcCtD
Nalbuphine—Dysgeusia—Doxorubicin—sarcoma	0.00225	0.00241	CcSEcCtD
Nalbuphine—Nervousness—Doxorubicin—sarcoma	0.00223	0.00239	CcSEcCtD
Nalbuphine—Vertigo—Epirubicin—sarcoma	0.00223	0.00239	CcSEcCtD
Nalbuphine—Syncope—Epirubicin—sarcoma	0.00223	0.00239	CcSEcCtD
Nalbuphine—Muscle spasms—Doxorubicin—sarcoma	0.00221	0.00237	CcSEcCtD
Nalbuphine—Loss of consciousness—Epirubicin—sarcoma	0.00218	0.00234	CcSEcCtD
Nalbuphine—Vision blurred—Doxorubicin—sarcoma	0.00217	0.00232	CcSEcCtD
Nalbuphine—Convulsion—Epirubicin—sarcoma	0.00215	0.0023	CcSEcCtD
Nalbuphine—Nausea—Etoposide—sarcoma	0.00215	0.0023	CcSEcCtD
Nalbuphine—Hypertension—Epirubicin—sarcoma	0.00215	0.0023	CcSEcCtD
Nalbuphine—Agitation—Doxorubicin—sarcoma	0.00211	0.00226	CcSEcCtD
Nalbuphine—Anxiety—Epirubicin—sarcoma	0.00211	0.00226	CcSEcCtD
Nalbuphine—Dry mouth—Epirubicin—sarcoma	0.00207	0.00221	CcSEcCtD
Nalbuphine—Vertigo—Doxorubicin—sarcoma	0.00207	0.00221	CcSEcCtD
Nalbuphine—Syncope—Doxorubicin—sarcoma	0.00206	0.00221	CcSEcCtD
Nalbuphine—Confusional state—Epirubicin—sarcoma	0.00204	0.00219	CcSEcCtD
Nalbuphine—Oedema—Epirubicin—sarcoma	0.00203	0.00217	CcSEcCtD
Nalbuphine—Loss of consciousness—Doxorubicin—sarcoma	0.00202	0.00216	CcSEcCtD
Nalbuphine—Shock—Epirubicin—sarcoma	0.002	0.00214	CcSEcCtD
Nalbuphine—Convulsion—Doxorubicin—sarcoma	0.00199	0.00213	CcSEcCtD
Nalbuphine—Hypertension—Doxorubicin—sarcoma	0.00199	0.00213	CcSEcCtD
Nalbuphine—Tachycardia—Epirubicin—sarcoma	0.00198	0.00212	CcSEcCtD
Nalbuphine—Hyperhidrosis—Epirubicin—sarcoma	0.00196	0.0021	CcSEcCtD
Nalbuphine—Anxiety—Doxorubicin—sarcoma	0.00195	0.00209	CcSEcCtD
Nalbuphine—Dry mouth—Doxorubicin—sarcoma	0.00191	0.00205	CcSEcCtD
Nalbuphine—Hypotension—Epirubicin—sarcoma	0.0019	0.00203	CcSEcCtD
Nalbuphine—Confusional state—Doxorubicin—sarcoma	0.00189	0.00203	CcSEcCtD
Nalbuphine—Oedema—Doxorubicin—sarcoma	0.00188	0.00201	CcSEcCtD
Nalbuphine—Shock—Doxorubicin—sarcoma	0.00185	0.00198	CcSEcCtD
Nalbuphine—Tachycardia—Doxorubicin—sarcoma	0.00183	0.00196	CcSEcCtD
Nalbuphine—Paraesthesia—Epirubicin—sarcoma	0.00182	0.00195	CcSEcCtD
Nalbuphine—Hyperhidrosis—Doxorubicin—sarcoma	0.00181	0.00194	CcSEcCtD
Nalbuphine—Dyspnoea—Epirubicin—sarcoma	0.00181	0.00194	CcSEcCtD
Nalbuphine—Somnolence—Epirubicin—sarcoma	0.0018	0.00193	CcSEcCtD
Nalbuphine—Dyspepsia—Epirubicin—sarcoma	0.00179	0.00191	CcSEcCtD
Nalbuphine—Hypotension—Doxorubicin—sarcoma	0.00175	0.00188	CcSEcCtD
Nalbuphine—Paraesthesia—Doxorubicin—sarcoma	0.00169	0.0018	CcSEcCtD
Nalbuphine—Dyspnoea—Doxorubicin—sarcoma	0.00167	0.00179	CcSEcCtD
Nalbuphine—Feeling abnormal—Epirubicin—sarcoma	0.00167	0.00179	CcSEcCtD
Nalbuphine—Somnolence—Doxorubicin—sarcoma	0.00167	0.00179	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Epirubicin—sarcoma	0.00166	0.00178	CcSEcCtD
Nalbuphine—Dyspepsia—Doxorubicin—sarcoma	0.00165	0.00177	CcSEcCtD
Nalbuphine—Urticaria—Epirubicin—sarcoma	0.00161	0.00172	CcSEcCtD
Nalbuphine—Body temperature increased—Epirubicin—sarcoma	0.0016	0.00172	CcSEcCtD
Nalbuphine—Abdominal pain—Epirubicin—sarcoma	0.0016	0.00172	CcSEcCtD
Nalbuphine—Feeling abnormal—Doxorubicin—sarcoma	0.00155	0.00166	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Doxorubicin—sarcoma	0.00153	0.00164	CcSEcCtD
Nalbuphine—Hypersensitivity—Epirubicin—sarcoma	0.00149	0.0016	CcSEcCtD
Nalbuphine—Urticaria—Doxorubicin—sarcoma	0.00149	0.0016	CcSEcCtD
Nalbuphine—Abdominal pain—Doxorubicin—sarcoma	0.00148	0.00159	CcSEcCtD
Nalbuphine—Body temperature increased—Doxorubicin—sarcoma	0.00148	0.00159	CcSEcCtD
Nalbuphine—Asthenia—Epirubicin—sarcoma	0.00146	0.00156	CcSEcCtD
Nalbuphine—Pruritus—Epirubicin—sarcoma	0.00143	0.00154	CcSEcCtD
Nalbuphine—Hypersensitivity—Doxorubicin—sarcoma	0.00138	0.00148	CcSEcCtD
Nalbuphine—Asthenia—Doxorubicin—sarcoma	0.00135	0.00144	CcSEcCtD
Nalbuphine—Dizziness—Epirubicin—sarcoma	0.00134	0.00144	CcSEcCtD
Nalbuphine—Pruritus—Doxorubicin—sarcoma	0.00133	0.00142	CcSEcCtD
Nalbuphine—Vomiting—Epirubicin—sarcoma	0.00129	0.00138	CcSEcCtD
Nalbuphine—Rash—Epirubicin—sarcoma	0.00128	0.00137	CcSEcCtD
Nalbuphine—Dermatitis—Epirubicin—sarcoma	0.00128	0.00137	CcSEcCtD
Nalbuphine—Headache—Epirubicin—sarcoma	0.00127	0.00136	CcSEcCtD
Nalbuphine—Dizziness—Doxorubicin—sarcoma	0.00124	0.00133	CcSEcCtD
Nalbuphine—Nausea—Epirubicin—sarcoma	0.0012	0.00129	CcSEcCtD
Nalbuphine—Vomiting—Doxorubicin—sarcoma	0.00119	0.00128	CcSEcCtD
Nalbuphine—Rash—Doxorubicin—sarcoma	0.00118	0.00127	CcSEcCtD
Nalbuphine—Dermatitis—Doxorubicin—sarcoma	0.00118	0.00127	CcSEcCtD
Nalbuphine—Headache—Doxorubicin—sarcoma	0.00118	0.00126	CcSEcCtD
Nalbuphine—Nausea—Doxorubicin—sarcoma	0.00111	0.00119	CcSEcCtD
